Cargando…

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia

Background: Acute myelogenous leukemia (AML) is nosocomial with the highest pediatric mortality rates and a relatively poor prognosis. C4.4A(LYPD3) is a tumorigenic and high-glycosylated cell surface protein that has been proven to be linked with the carcinogenic effects in solid tumors, but no hema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Tingting, Zhang, Yingjie, Yang, Tianqing, He, Qingnan, Zhao, Mingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963240/ https://www.ncbi.nlm.nih.gov/pubmed/35360840 http://dx.doi.org/10.3389/fgene.2022.795820

Ejemplares similares

Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia
por: Wang, Fengfeng, et al.
Publicado: (2016)

Nomogram Predicts Overall Survival in Patients With Stage IV Thyroid Cancer (TC): A Population-Based Analysis From the SEER Database
por: Yang, Tianqing, et al.
Publicado: (2022)

Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018)

Biomarkers for determining the prognosis in chronic myelogenous leukemia
por: Sweet, Kendra, et al.
Publicado: (2013)

Functional interaction between Lypd6 and nicotinic acetylcholine receptors
por: Arvaniti, Maria, et al.
Publicado: (2016)

Human LYPD8 protein inhibits motility of flagellated bacteria
por: Hsu, Chiao-Ching, et al.
Publicado: (2017)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia
por: Zheng, Jiafeng, et al.
Publicado: (2020)

Applications of Microarray Technology to Acute Myelogenous Leukemia
por: Goswami, Rashmi S., et al.
Publicado: (2008)

Heart-derived fibroblasts express LYPD-1 and negatively regulate angiogenesis in rat
por: Sakamoto, Satoru, et al.
Publicado: (2020)

Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery
por: Yang, Mingli, et al.
Publicado: (2014)

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021)

Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation
por: Liesveld, Jane
Publicado: (2012)

Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities
por: Flis, Sylwia, et al.
Publicado: (2019)

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
por: Karp, Judith E, et al.
Publicado: (2008)

Acute Myelogenous Leukemia Mimicking Fulminant Periorbital Cellulitis
por: Bagheri, Abbas, et al.
Publicado: (2013)

Familial Adenomatous Polyposis Complicated by Acute Myelogenous Leukemia
por: Alkofahi, Ala A, et al.
Publicado: (2020)

Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)

GluR2(Q) and GluR2(R) AMPA Subunits are not Targets of lypd2 Interaction
por: Lauriello, Anna, et al.
Publicado: (2022)

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
por: Martelli, Alberto M., et al.
Publicado: (2010)

NALCN is a potential biomarker and therapeutic target in human cancers
por: He, Jian, et al.
Publicado: (2023)

Relationship of an hRAD54 gene polymorphism (2290 C/T) in an Ecuadorian population with chronic myelogenous leukemia
por: Paz-y-Miño, César, et al.
Publicado: (2010)

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
Publicado: (1978)

Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
por: Ji, Qing, et al.
Publicado: (2016)

Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease
por: Watson, Callum N., et al.
Publicado: (2019)

Spinal epidural granulocytic sarcoma preceding acute myelogenous leukemia.
por: Kook, H., et al.
Publicado: (1992)

How mRNA is misspliced in acute myelogenous leukemia (AML)?
por: Mohamed, Aminetou Mint, et al.
Publicado: (2014)

Severe Intracranial Hemorrhage at Initial Presentation of Acute Myelogenous Leukemia
por: Balmages, Amanda, et al.
Publicado: (2018)

Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia
por: Guo, Naxin, et al.
Publicado: (2019)

Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers
por: Sobotka, Lindsay A., et al.
Publicado: (2019)

Genital Sweet's Syndrome in a patient with Acute Myelogenous Leukemia
por: Ensley, Daniel, et al.
Publicado: (2020)

Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia
por: Trybula, Marcus, et al.
Publicado: (2021)

Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
por: Ahmad, Rita, et al.
Publicado: (2021)

Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia
por: Wu, Hao, et al.
Publicado: (2022)

Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia
por: Murtadha, Mariam, et al.
Publicado: (2023)

Chronic myelogenous leukemia in ulcerative colitis
por: Katsanos, Konstantinos H., et al.
Publicado: (2011)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

Bosutinib in the management of chronic myelogenous leukemia
por: Amsberg, Gunhild Keller-von, et al.
Publicado: (2013)

Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017)

Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain
por: Kulbatskii, Dmitrii, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39kgqmhqja1ion6d0mvb3jmgmt